Physician profile
Kimberly Brune Shrum
NPI 1760798508
$984.87
in general payments reported to CMS, 2019-2025
11 companies · $397 in 2025
The $397 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $52.05 · 2023: $159 · 2024: $377 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $298.69 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Ibsa Pharma INC. | $155.44 | 2023-2025 | Tirosint, Licart, Flector |
| Abbvie INC. | $139.69 | 2025 | |
| Lilly USA, LLC | $134.41 | 2022-2025 | Zepbound, Jardiance, Mounjaro |
| Antares Pharma, INC. | $73.74 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Acella Pharmaceuticals, LLC | $68.28 | 2024-2025 | NP Thyroid 60 |
| Exact Sciences Corporation | $29.87 | 2024 | Cologuard Collection Kit |
| Halozyme INC | $28.48 | 2023 | |
| Qol Medical, LLC | $23.78 | 2025 | Sucraid |
| Abbott Laboratories | $18.10 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.39 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Brune Shrum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.